DD Support Board and Research Team

[shajandr]

"by trying to present the most current facts about this company and its products."

So answer the pending questions: How many millions/tens of millions of dollars has William A. Carter perssonally harvested from HEB and the predecessor company before being renamed to HEB in (1) salary, (2) bonuses, and (3) personal stock sales?

Since the 1980's, how many drugs has HEB or it's predecessor company gotten approved by the FDA and what is the aggregate amount of money that HEB and its predecessor company has received since the 1980s?

THAT is some basic diligence you ought to provide before pumping Carter's ongoing personal enrichment schemme.

Very basic diligence. If you can't answer that, you have no business promoting the pennystock by writing an article on SeekingAlpha.

Bonus question: what does the 1960's bulk RNA "Ampligen" do that is not done equally or better by CpG oligonucleotides and why has Ampligen never been approved by the FDA despite oodles of clinical trials since the 1960s??